A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy.
about
The Power of Zebrafish in Personalised Medicine.The novel autophagy inhibitor elaiophylin exerts antitumor activity against multiple myeloma with mutant TP53 in part through endoplasmic reticulum stress-induced apoptosis.Management and potentialities of primary cancer cultures in preclinical and translational studies.Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer.Zebrafish Models of Rare Hereditary Pediatric Diseases.
P2860
A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@en
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@nl
type
label
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@en
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@nl
prefLabel
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@en
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@nl
P2093
P2860
P1433
P1476
A clinically relevant in vivo ...... clinical therapeutic efficacy.
@en
P2093
Ariel H Kwart
Dongdong Ma
Jian-Jun Zhao
Jianhong Lin
Nikhil C Munshi
Robert I Handin
Weihong Zhang
Xiubao Ren
Yu-Tzu Tai
P2860
P304
P356
10.1182/BLOOD-2016-03-704460
P407
P577
2016-05-18T00:00:00Z